Antidepressant-like effects of NMDA-receptor antagonist injected into the dorsal hippocampus of rats

Pharmacology Biochemistry and Behavior

Volumn 77, Issue 1, 2004, Pages 15-19

  Padovan, C M ^a   Guimaraes F S ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Depression; Forced swim; Glutamate; Stress

Indexed keywords

2 AMINO 7 PHOSPHONOHEPTANOIC ACID;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFECT; DRUG EFFICACY; EXPERIMENTAL MODEL; FORCED SWIMMING TEST; HIPPOCAMPUS; IMMOBILIZATION; LATENT PERIOD; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALIA; RATTUS NORVEGICUS;

EID: 0346655105     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pbb.2003.09.015     Document Type: Article

References (36)

1. Bartanusz V., Aubry J.M., Pagliusi S., Jezova D., Baffi J., Kise J.Z. Stress-induced changes in messenger RNA levels of N-methyl-D-aspartate and AMPA receptor subunits in selected regions of rat hippocampus and hypothalamus. Neuroscience. 66:1995;247-252.
2. Gray J.A., McNaughton N. The neuropsychology of anxiety. 2nd ed. 2000;Oxford Univ. Press, Oxford.
3. Guimarães F.S., Carobrez A.P., De Aguiar J.C., Graeff F.G. Anxiolytic effect in the elevated plus-maze of the NMDA receptor antagonist AP7 microinjected into the dorsal periaqueductal grey. Psychopharmacology. 103:1991;91-94.
4. Guimarães F.S., Del Bel E.A., Padovan C.M., Mendonça Netto S., Titze-de-Almeida R. Hippocampal 5-HT receptors and consolidation of stressful memories. Behav. Brain Res. 58:1993;133-139.
5. Gutnikov S.A., Rawlins J.N. Systemic NMDA antagonist CGP-37849 produces non-specific impairment in a working memory task: the effect does not resemble those of AP5 and of lesions of the hippocampus or fornix. Neuropsychologia. 34:1996;311-314.
6. Izquierdo I., Medina J.H. Memory formation: the sequence of biochemical events in the hippocampus and its connection to activity in other brain structures. Neurobiol. Learn. Mem. 68(3):1997;285-316.
7. Kennett G.A., Dourish C.T., Curzon G. Antidepressant-like action of 5-HT1A agonists and conventional antidepressants in an animal model of depression. Eur. J. Pharmacol. 134:1987;265-274.
8. Kim J., Foy M.R., Thompson R.F. Behavioral stress modifies hippocampal plasticity through N-methyl-D-aspartate receptor activation. Proc. Natl. Acad. Sci. U. S. A. 93:1996;4750-4753.
9. Lino-de-Oliveira C., Guimarães F.S., Del Bel E.A. c-jun mRNA expression in the hippocampal formation induced by restraint stress. Brain Res. 753:1997;202-208.
10. Martijena I.D., Calvo N., Volosin M., Molina V.A. Prior exposure to a brief restraint session facilitates the occurrence of fear in response to a conflict situation: behavioral and neurochemical correlates. Brain Res. 752:1997;136-142.
11. McEwen B.S. Effects of adverse experiences for brains structure and function. Biol. Psychiatry. 48:2000;721-731.
12. Mendonça Netto S., Guimarães F.S. Role of hippocampal 5-HT1A receptors on elevated plus maze exploration after a single restraint experience. Behav. Brain Res. 77:1996;215-218.
13. Moghaddam B. Stress preferentially increases extraneuronal levels of excitatory amino acids in the prefrontal cortex: comparison to hippocampus and basal ganglia. J. Neurochem. 60:1993;1650-1657.
14. Nowak G., Trullas R., Layer R.T., Skolnick P., Paul I.A. Adaptive changes in the N-methyl-D-aspartate receptor complex after chronic treatment with imipramine and 1-amino-cyclopropanecarboxylic acid. J. Pharmacol. Exp. Ther. 265:1993;1380-1386.
15. Nowak G., Ordway G.A., Paul I.A. Alterations in the N-methyl-D-aspartate (NMDA) receptor complex in the frontal cortex of suicide victims. Brain Res. 675:1995;157-164.
16. Nowak G., Redmond A., McNamara M., Paul I.A. Swim stress increases the potency of glycine at the N-methyl-D-aspartate receptor complex. J. Neurochem. 64:1995;925-927.
17. Nowak G., Lie Y., Paul I.A. Adaptation of cortical but not hippocampal NMDA receptors after chronic citalopram treatment. Eur. J. Pharmacol. 295:1996;75-85.
18. Nowak G., Legato B., Skolnick P., Popik P. Adaptation of cortical NMDA receptors by chronic treatment with specific serotonin reuptake inhibitors. Eur. J. Pharmacol. 342:1998;367-370.
19. Padovan C.M., Guimarães F.S. Attenuation of behavioral consequences of immobilisation stress by intra-hippocampal microinjection of zimelidine. Braz. J. Med. Biol. Res. 26:1993;1085-1089.
20. Padovan C.M., Guimarães F.S. Restraint-induced hypoactivity in an elevated plus-maze. Braz. J. Med. Biol. Res. 33(1):2000;79-83.
21. Padovan C.M., Del Bel E.A., Guimarães F.S. Behavioral effects in the elevated plus-maze of an NMDA antagonist injected into the dorsal hippocampus: influence of restraint stress. Pharmacol. Biochem. Behav. 67:2000;325-330.
22. Paul I.A., Trullas R., Skolnick P., Nowak G. Down-regulation of cortical β-adrenoceptors by chronic treatment with functional NMDA receptor antagonists. Psychopharmacology. 106:1992;285-287.
23. Paul I.A., Layer R.T., Skolnick P., Nowak G. Adaptation of the NMDA receptor in rat cortex following chronic electroconvulsive shock or imipramine. Eur. J. Pharmacol. 247:1993;305-311.
24. Paul I.A., Nowak G., Layer R.T., Popik P., Skolnick P. Adaptation of N-methyl-D-aspartate receptor complex following chronic antidepressant treatments. J. Pharmacol. Exp. Ther. 269:1994;95-102.
25. Paxinos G., Watson C. The rat brain in stereotaxic coordinates. 2nd ed. 1986;Academic Press, San Diego.
26. Popik P., Wróbel M., Nowak G. Chronic treatment with antidepressants affects glycine/NMDA receptor function: behavioral evidence. Neuropharmacology. 39:2000;2278-2287.
27. Porsolt A.D., LePichon M., Jalfre M. Depression: a new animal model sensitive to antidepressant treatment. Nature. 266:1977;730-732.
28. Post R.M. Transduction of psychosocial stress into the neurobiology of recurrent depressive disorder. Am. J. Psychiatry. 149(8):1992;999-1010.
29. Przegalinski E., Tatarczynska E., Deren-Wesolek A., Chojnacka-Wojcik E. Antidepressant-like effects of a partial agonist at strychnine-insensitive glycine receptors and competitive NMDA receptor antagonist. Neuropharmacology. 36:1997;31-37.
30. Skolnick P., Miller R., Young A., Boje K., Trullas R. Chronic treatment with 1-aminocyclopropanecarboxylic acid desensitizes behavioral responses to compounds acting at the N-methyl-D-aspartate receptor complex. Psychopharmacology. 107:1992;489-496.
31. Skolnick P., Layer R.T., Popik P., Nowak G., Paul I.A., Trullas R. Adaptation of N-methyl-D-aspartate (NMDA) receptors following antidepressant treatment: implications for the pharmacotherapy of depression. Pharmacopsychiatry. 29:1996;23-26.
32. Titze-de-Almeida R., Lino de Oliveira C., Shida H.W., Guimarães F.S., Del Bel E.A. Midazolam and the N-methyl-D-aspartate (NMDA) receptor antagonist 2-amino-7-phosphono-heptanoic acid (AP-7) attenuate stress-induced expression of c-fos mRNA in the dentate gyrus. Cell. Mol. Neurobiol. 14:1994;373-380.
33. Trullas R., Skolnick P. Functional antagonists at the NMDA receptor complex exhibit antidepressant action. Eur. J. Pharmacol. 185:1990;1-10.
34. Watkins J.C., Krogsgaard-Larsen P., Honoré T. Structure-activity relationships in the development of excitatory amino acid receptor agonists and competitive antagonists. T.I.P.S. 11:1990;25-33.
35. Willner P. Animal models of depression: an overview. Pharmacol. Ther. 45:1990;425-455.
36. Young A.B., Fagg G.E. Excitatory amino acid receptors in the brain: membrane binding and receptor auto-radiographic approaches. T.I.P.S. 11:1990;126-132.